Details of the Drug

General Information of Drug (ID: DMILD4U)

• Drug Name: LRX712

Indication

Disease Entry	ICD 11	Status	REF
Osteoarthritis	FA00-FA05	Phase 2	[1]

• Cross-matching ID: TTD ID: DFV73I

References

• [1] ClinicalTrials.gov (NCT04097379) A Randomized, Placebo-controlled, Subject and Investigator Blinded Study Investigating the Safety, Tolerability and Preliminary Efficacy of 8-week Treatment With Intra-articular LRX712 to Regenerate Articular Cartilage in Patients With Mild/Moderate Knee Osteoarthritis. U.S.National Institutes of Health.